|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update on biomarkers of glycemic control显示文摘Attaining and maintaining good glycemic control is a cornerstone of diabetes care. The monitoring of glycemic control is currently based on the self-monitoring of blood glucose(SMBG) and laboratory testing for hemoglobin A1 c(HbA1 c),which is a surrogate biochemical marker of the average glycemia level over the previous 2-3 mo period. Although hyperglycemia is a key biochemical feature of diabetes, both the level of and exposure to high glucose, as well as glycemic variability, contribute to the pathogenesis of diabetic complications and follow different patterns in type 1 and type 2 diabetes. HbA1 c provides a valuable,standardized and evidence-based parameter that is relevant for clinical decision making, but several biological and analytical confounders limit its accuracy in reflecting true glycemia. It has become apparent in recent years that other glycated proteins such as fructosamine, glycated albumin, and the nutritional monosaccharide 1,5-anhydroglucitol, as well as integrated measures from direct glucose testing by an SMBG/continuous glucose monitoring system, may provide valuable complementary data, particularly in circumstances when HbA1 c results may be unreliable or are insufficient to assess the risk of adverse outcomes. Long-term associations of these alternative biomarkers of glycemia with the risk of complications need to be investigated in order to provide clinically relevant cut-off values and to validate their utility in diverse populations of diabetes patients. | Maja Krhac Marijana Vucic Lovrencic | 2019 | World Journal of Diabetes2019，10，1： | 5 |
| 2 | 动脉粥样硬化和基质金属蛋白酶:活体分子MR成像实验研究显示文摘目的评价以基质金属蛋白酶(MMPs)作为靶目标的分子MR成像对比剂P947检测和成像活体动脉粥样硬化病变中基质金属蛋白酶的能力:比较其与P1135的特异度:明确基质金属蛋白酶在动脉粥样硬化血管中的表达与分布:应用荧光标记P947(Eu—P947)在体内的分布和分子定位。方法动物保护与应用委员会批准进行所有实验。将钆螯合物(1,4,7,10-tetraazacvclododecane-N,N_,N_,N_—tetraaceticacidl与一能与MMPs特异结合的多肽黏附合成P947。 | V. Amirbekian J.G. Aguinaldo S. Amirbekian F. Hyafil E. Vucic M. Sirol 郭瑜(译) 葛夕洪(校) | 2009 | 国际医学放射学杂志2009，32，4： | 4 |
| 3 | Crosstalk between dietary patterns,obesity and nonalcoholic fatty liver disease显示文摘The prevalence of nonalcoholic fatty liver disease(NAFLD)is rising worldwide,paralleling the epidemic of obesity.The liver is a key organ for the metabolism of proteins,fats and carbohydrates.Various types of fats and carbohydrates in isocaloric diets differently influence fat accumulation in the liver parenchyma.Therefore,nutrition can manage hepatic and cardiometabolic complications of NAFLD.Even moderately reduced caloric intake,which leads to a weight loss of 5%-10%of initial body weight,is effective in improving liver steatosis and surrogate markers of liver disease status.Among dietary patterns,the Mediterranean diet mostly prevents the onset of NAFLD.Furthermore,this diet is also the most recommended for the treatment of NAFLD patients.However,clinical trials based on the dietary interventions in NAFLD patients are sparse.Since there are only a few studies examining dietary interventions in clinically advanced stages of NAFLD,such as active and fibrotic steatohepatitis,the optimal diet for patients in these stages of the disease must still be determined.In this narrative review,we aimed to critically summarize the associations between different dietary patterns,obesity and prevention/risk for NAFLD,to describe specific dietary interventions’impacts on liver steatosis in adults with NAFLD and to provide an updated overview of dietary recommendations that clinicians potentially need to apply in their daily practice. | Danijela Ristic-Medic Joanna Bajerska Vesna Vucic | 2022 | World Journal of Gastroenterology2022，28，27： | 2 |
| 4 | Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945显示文摘 | Esad Vucic Claudia Calcagno Stephen D. Dickson James H.F. Rudd Katsumi Hayashi Jan Bucerius Erin Moshier Jessica S. Mounessa Michelle Roytman Matthew J. Moon James Lin Sarayu Ramachandran Tatsuo Tanimoto Karen Brown Masakatsu Kotsuma Sotirios Tsimikas Edw | 2012 | JACC: Cardiovascular Imaging2012，，8： | 2 |
| 5 | ML - IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas 显示文摘 | Vucic D Stennicke H R Pisabarro M T | 2000 | Curr Biol2000，10，21： | 1 |
| 6 | Engineering ML-IAP to produre an extraordinarily potent caspase-9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP显示文摘 | Vucic D Frankin MC Walweer HJ | 2005 | Biochem J2005，385，1： | 1 |
| 7 | FOSMN syndrome: novel insight into disease pathophysiology显示文摘 | Vucic S Stein TD Hedley-Whyte ET | 2012 | Neurology2012，79，： | 1 |
| 8 | Human cancer long non- coding RNA transcriptomes显示文摘 | Gibb EA Vucic EA En field KS | 2011 | PLoS One2011，6，25： | 1 |
| 9 | ML-IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas显示文摘 | Stennicke HR Pisabarro MT | 2000 | Curr Biol2000，10，21： | 1 |
| 10 | Engi- neering ML - IAP to produce an extraordinarily potent caspase 9 inhibitor: implication for Smac- dependent anti- apoptotic activi- ty of ML - IAP显示文摘 | VUCIC D FRANKLIN M C WALLWEBER H J | 2005 | Biochem J2005，385，1： | 1 |
| 11 | Engineering MLIAP to produce an extraordinarily potent caspase 9 inhibitor:implications for smac-dependent anti-apoptotic activity of ML-IAP显示文摘 | Vucic D Franklin MC Wallweber HJ | | 0，，1： | 1 |
| 12 | Future Internet as a Driver for Virtualization, Connectivity and Intelligence of Agri-Food Supply Chain Networks 显示文摘 | VERDOUW C N VUCIC N SUNDMAEKER H | 2014 | International Journal on Food System Dynamics2014，，4： | 1 |
| 13 | Engineering ML IAP to produce an extraordinarily potent caspase-9 inhibitor:implications for Smac-dependent anti-apoptotic activity of ML-IAP 显示文摘 | Vucic D Frankin M C Walweber H J | 2005 | Biochem J2005，385，1： | 1 |
| 14 | Differentatial activation of the inflammasome by casepase-adaptors ASC and Ipaf 显示文摘 | Mariathasan S Newton K Monack D M Vucic D French D M Lee W P | 2004 | Nature2004，430，： | 1 |
| 15 | Spectral correlation evaluation of MSK and offset QPSK modulation显示文摘 | Vucic D and Obradovic M | 1999 | Signal Processing1999，78，3： | 1 |
| 16 | Neurophysiological index as a biomarker for ALS progression:validity of mixed effects models显示文摘 | Cheah BC Vucic S Krishnan AV | 2011 | Amyotroph Lateral Scler2011，12，1： | 1 |
| 17 | ML - IAP, a novel inhibitor of apoptosis that is preferentially expresses in human melanomas显示文摘 | Vucic D Stennicke HR Pisabarro MT | 2000 | Current Biol2000，10，： | 1 |
| 18 | M-IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas显示文摘 | Vucic D Stennicke HR Pisabarrom T | 2000 | Curr Bio I2000，10，： | 1 |
| 19 | Pure motor mononeuropathy with distal conduction block: an unusual presentation of multifocal motor neuropathy with conduction blocks显示文摘 | Vucic S Dawson K Sun D | 2004 | Clin Neurophysiol2004，115，10： | 1 |
| 20 | ML-IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas显示文摘 | Vucic D Stennicke HR Pisabarro MT | 2000 | Curt Biol2000，10，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员